MedsChat.com

The People's Medicine Community ®
Drug Index: 

Zinecard

Active Ingredient(s): Dexrazoxane
FDA Approved: May 26, 1995
Pharm Company: PHARMACIA AND UPJOHN
Category: Cancer

Welcome to the Zinecard information hub. Scroll down to read supplemental details and discuss this drug.


Zinecard Overview

Dexrazoxane hydrochloride (Zinecard by Pfizer in USA and Canada; Cardioxane by Novartis for EU and other countries) is a cardioprotective agent. It was discovered by Kurt Hellmann in 1972. Dexrazoxane is a sterile, pyrogen-free lyophilizate intended for intravenous administration. The IV administration of dexrazoxane is in acidic condition with HCl adjusting the pH.[1] Uses Dexrazoxane has been used to protect the heart against the cardiotoxic side effects of chemotherapeutic drugs such as ...

Read more Zinecard Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: http://en.wikipedia.org/wiki/Dexrazoxane

Recent Zinecard Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Dexrazoxane
  • Injection: 250mg, 250mg/vial, 500mg, 500mg/vial
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

Other drugs which contain Dexrazoxane or a similar ingredient: (2 results)